Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01177709 · ClinicalTrials.gov registry record · NA
Metformin for Weight Loss in Schizophrenia
A NA study, sponsored by Nathan Kline Institute for Psychiatric Research.
- Terminated
- Registry status
- NA
- Development phase
- 12
- Enrollment target
NCT01177709 is a NA study that was terminated before completion, run by Nathan Kline Institute for Psychiatric Research. The registered enrollment target is 12 participants.
The verdict
NCT01177709, a NA study, was terminated before completion, sponsored by Nathan Kline Institute for Psychiatric Research.
- TERMINATED
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
Study Summary
Study hypothesis is that patients on antipsychotics medication treated with metformin will show loss in weight and improved measures of glucose metabolism.
Interventions
- DRUG Metformin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2008-05 |
| Est. Completion | 2011-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01177709
The ClinicalTrials.gov registry entry for NCT01177709 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Nathan Kline Institute for Psychiatric Research, which has 20 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Metformin is the first listed.
NCT01177709 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01177709 about?
NCT01177709 is a clinical study titled "Metformin for Weight Loss in Schizophrenia". Study hypothesis is that patients on antipsychotics medication treated with metformin will show loss in weight and improved measures of glucose metabolism.
What is the current status of trial NCT01177709?
This trial is currently terminated. It is a NA study. The enrollment target is 12 participants. The study started on 2008-05. Estimated completion is 2011-04.
What interventions are being tested in trial NCT01177709?
The interventions under investigation include: Metformin (DRUG).
Who is sponsoring clinical trial NCT01177709?
This trial is sponsored by Nathan Kline Institute for Psychiatric Research, which has 20 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.